Question 1

What are the most cited papers from Excelitas Technologies (Germany)?

Accepted Answer

The most cited paper from Excelitas Technologies (Germany) is "Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial" (Gennaro Pagano et al., 2024), with 60 citations. Next come "First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)" (41) and "Chlorine partitioning in the lowermost Arctic vortex during the cold winter 2015/2016" (27).

Question 2

Which research topics does Excelitas Technologies (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Optical Coherence Tomography Applications, Health, Nursing, Elderly Care, Additive Manufacturing and 3D Printing Technologies and Innovation and Socioeconomic Development.

Question 3

Which keywords describe research at Excelitas Technologies (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Public Health, Health Policy, Healthcare Access, Innovation, Sustainability, Biomedical Engineering, Biomedical Applications and Primary Care.

Question 4

Which fields of science does Excelitas Technologies (Germany) work in?

Accepted Answer

In all years, 51% of research at Excelitas Technologies (Germany) is in Physical Sciences, 24% in Health Sciences. Its largest fields are Engineering (31%), Medicine (14%), Health Professions (10%).

Question 5

Is Excelitas Technologies (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 244% higher than in 2018-2021.